315 related articles for article (PubMed ID: 12650894)
1. [Inhibitors of TNFalpha].
Brousse C
Rev Med Interne; 2003 Feb; 24(2):123-6. PubMed ID: 12650894
[TBL] [Abstract][Full Text] [Related]
2. Anti-TNF agents for rheumatoid arthritis.
Seymour HE; Worsley A; Smith JM; Thomas SH
Br J Clin Pharmacol; 2001 Mar; 51(3):201-8. PubMed ID: 11298065
[TBL] [Abstract][Full Text] [Related]
3. Biological and clinical effects of anti-TNFalpha treatment.
Valesini G; Iannuccelli C; Marocchi E; Pascoli L; Scalzi V; Di Franco M
Autoimmun Rev; 2007 Nov; 7(1):35-41. PubMed ID: 17967723
[TBL] [Abstract][Full Text] [Related]
4. [Biologic therapy with anti-TNFα in spondyloarthritides and other autoimmune diseases].
Lapadula G
Reumatismo; 2005; 57(4 Suppl):22-9. PubMed ID: 16385352
[TBL] [Abstract][Full Text] [Related]
5. [Copernican revolution in the therapy of rheumatoid arthritis: the contribution of anti-TNFalpha drugs].
Bombardieri S; Ferraccioli G; Ferri C; Galeazzi M; Lapadula G; Cerinic MM; Montecucco C; Triolo G; Trotta F; Valentini G
Reumatismo; 2009; 61 Suppl 1():1-23. PubMed ID: 19999184
[TBL] [Abstract][Full Text] [Related]
6. TNFalpha inhibitors may improve asthma symptoms: a case series of 12 patients with rheumatoid arthritis and asthma.
Stoll ML; Solomon DH; Batra KL; Simard JF; Karlson EW; Dellaripa PF; Weinblatt ME; Glass R; Shadick NA
J Clin Rheumatol; 2009 Jun; 15(4):198-200. PubMed ID: 19455057
[No Abstract] [Full Text] [Related]
7. TNFalpha as therapeutic target: new drugs, more applications.
Reimold AM
Curr Drug Targets Inflamm Allergy; 2002 Dec; 1(4):377-92. PubMed ID: 14561184
[TBL] [Abstract][Full Text] [Related]
8. [Biologic therapy with anti-TNFα in rheumathoid arthritis].
Ferraccioli G
Reumatismo; 2005; 57(4 Suppl):17-21. PubMed ID: 16385351
[TBL] [Abstract][Full Text] [Related]
9. Infliximab induced T lymphocyte apoptosis in Crohn's disease.
van den Brande J; Hommes DW; Peppelenbosch MP
J Rheumatol Suppl; 2005 Mar; 74():26-30. PubMed ID: 15742461
[TBL] [Abstract][Full Text] [Related]
10. [Value of anti-TNF-alpha molecules in inflammatory and infectious diseases].
Fautrel B; Cherin P
Rev Med Interne; 2000 Oct; 21(10):872-88. PubMed ID: 11075396
[TBL] [Abstract][Full Text] [Related]
11. Effects of etanercept or infliximab treatment on lipid profile and insulin resistance in patients with refractory rheumatoid arthritis.
Seriolo B; Paolino S; Ferrone C; Cutolo M
Clin Rheumatol; 2007 Oct; 26(10):1799-800. PubMed ID: 17646897
[No Abstract] [Full Text] [Related]
12. Transcending conventional therapies: the role of biologic and other novel therapies.
Sandborn WJ
Inflamm Bowel Dis; 2001 May; 7 Suppl 1():S9-16. PubMed ID: 11380043
[TBL] [Abstract][Full Text] [Related]
13. Lipid profile of rheumatoid arthritis patients treated with anti-tumor necrosis factor-alpha drugs changes according to disease activity and predicts clinical response.
Cacciapaglia F; Anelli MG; Rinaldi A; Serafino L; Covelli M; Scioscia C; Iannone F; Lapadula G
Drug Dev Res; 2014 Nov; 75 Suppl 1():S77-80. PubMed ID: 25381986
[TBL] [Abstract][Full Text] [Related]
14. Golimumab in patients with active rheumatoid arthritis after treatment with tumour necrosis factor alpha inhibitors (GO-AFTER study): a multicentre, randomised, double-blind, placebo-controlled, phase III trial.
Smolen JS; Kay J; Doyle MK; Landewé R; Matteson EL; Wollenhaupt J; Gaylis N; Murphy FT; Neal JS; Zhou Y; Visvanathan S; Hsia EC; Rahman MU;
Lancet; 2009 Jul; 374(9685):210-21. PubMed ID: 19560810
[TBL] [Abstract][Full Text] [Related]
15. [Anti-TNF alpha agents in patients with rheumatoid arthritis refractory to conventional therapies].
González-Gay MA; Agudo M
Med Clin (Barc); 2010 May; 134(15):684-5. PubMed ID: 20176386
[No Abstract] [Full Text] [Related]
16. Inhibitors of tumor necrosis factor: new treatment options for rheumatoid arthritis.
Moreland LW
Cleve Clin J Med; 1999 Jun; 66(6):367-74. PubMed ID: 10375846
[TBL] [Abstract][Full Text] [Related]
17. Biological disease modifying anti-rheumatic drugs.
Cranwell-Bruce LA
Medsurg Nurs; 2011; 20(3):147-50. PubMed ID: 21786492
[No Abstract] [Full Text] [Related]
18. [Etanercept--infliximab switch in rheumatoid arthritis 14 out of 131 patients treated with anti TNFalpha].
Brocq O; Plubel Y; Breuil V; Grisot C; Flory P; Mousnier A; Euller-Ziegler L
Presse Med; 2002 Nov; 31(39 Pt 1):1836-9. PubMed ID: 12496713
[TBL] [Abstract][Full Text] [Related]
19. [Effects of TNF antagonists on immune and neuroendocrine system].
Valesini G; Cutolo M
Reumatismo; 2005; 57(4 Suppl):3-7. PubMed ID: 16385349
[TBL] [Abstract][Full Text] [Related]
20. Tumour necrosis factor inhibitors.
Nash PT; Florin TH
Med J Aust; 2005 Aug; 183(4):205-8. PubMed ID: 16097922
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
